BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2027-01

167 industry Phase 2/3 trial readout(s) and 3 FDA decision event(s). Active trials only; estimated dates often slip.

← 2026-12 | 2027-02 →

FDA decision events

DateEventStatusCompanyDrugSource
2027-01-01 (quarter)PDUFA date (company-disclosed)pendingBiohaven Ltd. BHVNPDUFA first quarter of 2027 - Biohaven Ltd.
2027-01-01 (quarter)PDUFA date (company-disclosed)pendingCorMedix Inc. CRMDPDUFA Q1 2027 - CorMedix Inc.
2027-01-21PDUFA date (company-disclosed)pendingDyne Therapeutics, Inc. DYNrostudirsenPDUFA January 21, 2027 - Dyne Therapeutics, Inc. (rostudirsen)

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2027-01 est.P2ImvaxNCT04485949 A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With GlioblastomaGlioblastomaactive not recruiting99
2027-01 est.P1/P2BicycleTx LimitedNCT04561362 Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced MalignanciesUrinary Bladder Neoplasm; Triple Negative Breast Neoplasms; Hormone Receptor Positive, HER2-negativeactive not recruiting329
2027-01 est.P1/P2Eledon Pharmaceuticals ELDNNCT05027906 Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney TransplantPrevention of Rejection in Kidney Transplantrecruiting48
2027-01 est.P2Mirum Pharmaceuticals, Inc. MIRMNCT05050136 A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary CholangitisPrimary Biliary Cholangitis; PBCactive not recruiting333
2027-01 est.P2Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.NCT05171894 A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDTPort-wine Birthmarks; Port-Wine Stain; Nevus Flammeusrecruiting84
2027-01 est.P3Vantive Health LLCNCT05399537 Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRTRegional Citrate Anticoagulation (RCA); Continuous Renal Replacement Therapy (CRRT); Acute Kidney Inrecruiting40
2027-01 est.P1/P2Vaderis Therapeutics AGNCT05406362 Assess Safety and Efficacy of VAD044 in HHT PatientsHereditary Hemorrhagic Telangiectasia (HHT)active not recruiting75
2027-01 est.P2Edgewise Therapeutics, Inc. EWTXNCT05540860 A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)Duchenne Muscular Dystrophyactive not recruiting76
2027-01 est.P3BiocadNCT05751928 A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin MelanomaMelanoma Stage III; Melanoma (Skin)active not recruiting411
2027-01 est.P2QBiotics Group LimitedNCT05755113 A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue SarcomaSoft Tissue Sarcomarecruiting40
2027-01 est.P3EMSNCT05824065 Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair LossFemale Pattern Baldnessnot yet recruiting504
2027-01 est.P1/P2LigaChem Biosciences, Inc.NCT05941507 A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid TumorsAdvanced Solid Tumorsrecruiting300
2027-01 est.P1/P2Skyline Therapeutics (US) Inc.NCT05986864 Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)Neovascular Age-related Macular Degenerationrecruiting68
2027-01 est.P2Gilead Sciences GILDNCT06029972 Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative ColitisUlcerative Colitisactive not recruiting176
2027-01 est.P2Dr. F. Köhler Chemie GmbHNCT06032195 Study of Organ Perfusion in Heart Transplantation in ChildrenHeart Transplantationrecruiting15
2027-01 est.P2/P3AbbVie ABBVNCT06109272 A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as aHepatocellular Carcinomaactive not recruiting89
2027-01 est.P1/P2Sichuan Baili Pharmaceutical Co., Ltd.NCT06131450 A Study of BL-M07D1 in Patients With Recurrent or Metastatic Gynecologic MalignanciesGynecological Malignanciesrecruiting158
2027-01 est.P2OncoVerity, Inc.NCT06384261 A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive TherapyLeukemia, Myeloid, Acuteactive not recruiting140
2027-01 est.P1/P2Jacobio Pharmaceuticals Co., Ltd.NCT06386146 JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C MutationSolid Tumorsrecruiting144
2027-01 est.P2Larimar Therapeutics, Inc. LRMRNCT06447025 An Open-Label Study of CTI-1601 in Subjects With Friedreich's AtaxiaFriedreich Ataxiarecruiting85
2027-01 est.P3Lexicon Pharmaceuticals LXRXNCT06481891 A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic CardiomyopathyObstructive Cardiomyopathy, Hypertrophic; Non-obstructive Hypertrophic Cardiomyopathyactive not recruiting500
2027-01 est.P3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06561607 A Clinical Trial of TQB2102 for Injection in the Treatment of HER2 Low-Expressing Recurrent/Metastatic Breast CancerBreast Canceractive not recruiting542
2027-01 est.P3AkesoNCT06601335 A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)Head and Neck Squamous Cell Carcinomarecruiting510
2027-01 est.P3Ultragenyx Pharmaceutical Inc RARENCT06636071 Setrusumab in Pediatric Japanese Subjects With Osteogenesis ImperfectaOsteogenesis Imperfectaactive not recruiting6
2027-01 est.P2Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)NCT06672978 A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including AcutAcute Pyelonephritis; Complicated Urinary Tract Infectionactive not recruiting66
2027-01 est.P3AbbVie ABBVNCT06701331 Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to SevereAtopic Dermatitisactive not recruiting99
2027-01 est.P2Evopoint Biosciences Inc.NCT06702605 To Evaluate XNW5004 Tablets in Patients with Relapsed or Refractory Peripheral T Cell LymphomaRelapsed/Refractory Peripheral T Cell Lymphomanot yet recruiting50
2027-01 est.P1/P2AION Healthspan, Inc.NCT06721143 A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered Chronic Kidney Disease Stage 3recruiting36
2027-01 est.P1/P2CStone PharmaceuticalsNCT06741644 A Phase I/II Study of CS2009 in Participants With Advanced Solid TumorsAdvanced Solid Tumorsrecruiting800
2027-01 est.P2Hope Biosciences Research FoundationNCT06800404 "HB-adMSCs for the Treatment of Patients With Multiple Sclerosis"Relapsing Remitting Multiple Sclerosis (RRMS); Multiple Sclerosisactive not recruiting10
2027-01 est.P1/P2Marengo Therapeutics, Inc.NCT06827613 A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab GovitTriple Negative Locally Advanced Non-resectable Breast Cancer; HR+, HER2-, Advanced Breast Cancerrecruiting50
2027-01 est.P3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06860971 A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid CarcinomaThyroid Cancerrecruiting144
2027-01 est.P3ResilienceNCT06867705 Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care As Usual OnlyCancerrecruiting1458
2027-01 est.P2/P3QED Therapeutics, a BridgeBio companyNCT06873035 An Interventional Study of Infigratinib in Children With HypochondroplasiaHypochondroplasiaenrolling by invitation24
2027-01 est.P1/P2iOncturaNCT06879717 A Study of Roginolisib (IOA-244) in Combination With Dostarlimab With or Without Docetaxel in Metastatic Non Small-cell Lung Cancer (NSCLC) PatientsNon-Squamous Non-Small Cell Lung Cancer (NSCLC); Advanced Non Squamous NSCLCactive not recruiting45
2027-01 est.P2Zhejiang Teruisi Pharmaceutical Inc.NCT06886139 A Phase 2 Study of TRS005 in Patients With CD20-positive R/R DLBCL.CD20-positive Diffuse Large B-Cell Lymphomanot yet recruiting139
2027-01 est.P1/P2TenNor Therapeutics Inc.NCT06889701 A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI ParticipantsPeriprosthetic Joint Infection (PJI)recruiting33
2027-01 est.P3Xenon Pharmaceuticals Inc. XENENCT06922110 An Open-Label Study of Azetukalner in Major Depressive DisorderMajor Depressive Disorderactive not recruiting460
2027-01 est.P2BioMendics, LLCNCT07027345 A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa SimplexEpidermolysis Bullosa Simplexrecruiting40
2027-01 est.P2Greg BewNCT07032649 Evaluating Benzoyl Peroxide for Preventing Recurrence of HSV-1 Outbreaks With Rescue Crossover OptionHSVnot yet recruiting100
2027-01 est.P1/P2EyeD PharmaNCT07036510 Safety and Efficacy of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract SurgeryGlaucoma; Ocular Hypertensionrecruiting42
2027-01 est.P2Shanghai Henlius BiotechNCT07038382 A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in PMembranous Nephropathy; Lupus Nephritis (LN)recruiting24
2027-01 est.P3Telix Pharmaceuticals (Innovations) Pty Limited TLXNCT07052214 PSMA PET Combined With MRI for the Detection of PCaPCA; Prostate Cancer; Prostatic Neoplasm; PSMA PET; Diagnostic Imaging; Elevated PSA; Positron Emissactive not recruiting338
2027-01 est.P3Qilu Pharmaceutical Co., Ltd.NCT07062978 A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®Postmenopausal Women With Osteoporosis at High Risk of Fracturerecruiting278
2027-01 est.P2BiocadNCT07080034 Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative ColitisUlcerative Colitis (UC)recruiting198
2027-01 est.P3Sun Pharmaceutical Industries, Inc.NCT07144345 Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and ScalpActinic Keratosisrecruiting160
2027-01 est.P3Sun Pharmaceutical Industries, Inc.NCT07144852 Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper ExtremitiesActinic Keratosisrecruiting260
2027-01 est.P3Shanghai Huilun Pharmaceutical Co., Ltd.NCT07146386 A Phase III Clinical Study of H077 Sustained-Release Tablets Compared With Silodosin Capsules in the Treatment of Benign Prostatic HyperplasiaBenign Prostatic Hyperplasia; Benign Prostatic Hyperplasia With Lower Urinary Tract Symptomsnot yet recruiting728
2027-01 est.P1/P2Alesta TherapeuticsNCT07179640 A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy Adults and Adults With Hypophosphatasia in Order to Identify SuHypophosphatasia (HPP)recruiting120
2027-01 est.P2Hanmi Pharmaceutical Company Limited HAFCNCT07205900 Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes MellitusObese; Obesityactive not recruiting267
2027-01 est.P1/P2MediLink Therapeutics (Suzhou) Co., Ltd.NCT07208773 A Study of YL201 and Ivonescimab (AK112) in Advanced Solid TumorsAdvanced Solid Tumors; Non Small Cell Lung Cancer; Small Cell Lung Cancerrecruiting260
2027-01 est.P1/P2Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT07298772 A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid TumorsAdvanced Solid Tumorrecruiting198
2027-01 est.P2Newleos Therapeutics, Inc.NCT07323784 A Study of NTX-1472 in Social Anxiety DisorderSocial Anxiety Disorder (SAD)recruiting100
2027-01 est.P1/P2Inflammasome TherapeuticsNCT07396818 Kamlanoflast In Amyotrophic Lateral SclerosisALS (Amyotrophic Lateral Sclerosis); ALS; Neuro-Degenerative Disease; Neuro-Degenerative Diseases; Mnot yet recruiting40
2027-01 est.P2Synendos Therapeutics AGNCT07478744 A Phase 2a Efficacy, Safety, Tolerability, and PK Study of SYT-510 in Participants With Generalized Anxiety DisorderGeneralized Anxiety Disorderrecruiting24
2027-01 est.P2Aribio Lab Co., Ltd.NCT07481604 Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and AboveHerpes Zosteractive not recruiting135
2027-01 est.P3Praxis Precision Medicines PRAXNCT07505004 Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal SeizuresFocal Epilepsyactive not recruiting300
2027-01 est.P3Sinovac Biotech Co., Ltd SVANCT07505836 Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 MonthsEpidemic Meningitis; Meningococcal Vaccinesrecruiting1040
2027-01 est.P3Reistone Biopharma Company LimitedNCT07543224 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients WPlaque Psoriasis Subjectsnot yet recruiting600
2027-01 est.P2Lakewood-Amedex Inc LABTNCT07565506 Phase 2a Dose Finding Study of Nu-3 Gel in Subjects With Mild iDFUDiabetic Foot Ulcers (DFUs)recruiting24
2027-01 est.P2/P3Hyundai Bioscience Co., Ltd.NCT07576868 A Study of CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2)Denguerecruiting210
2027-01 est.P2Actio Biosciences, Inc.NCT07600736 A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of ABS-1230 in Pediatric and Young Adult Participants With KCNT1-relateKCNT1-Related Epilepsyrecruiting61
2027-01 est.P3A. Menarini International Licensing S.A.NCT07614958 Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Mixed Dyslipidemia; Hypercholesterolaemiarecruiting426
2027-01 est.P1/P2Prolium Bioscience, IncNCT07641634 A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.Healthy Volunteers; Systemic Sclerosis (SSc); Scleroderma, Systemic; Sclerodermarecruiting44
2027-01 est.P2Sensory Cloud, Inc.NCT07690059 A Study to Investigate the Efficacy and Safety of SC0032, a Magnesium Salt Oral Spray, in Adults With Refractory or Unexplained Chronic CoughRefractory Chronic Cough and Unexplained Chronic Coughrecruiting60
2027-01 est.P2Caravel Oculus Pty LtdNCT07694375 A Study of CA201A Eye Drops to Prevent Corneal Endothelial Cell Loss in Patients Undergoing Cataract SurgeryCorneal Endothelial Cell Loss; Corneal Endothelial Damage Following the Hard Nuclear Cataract Surgerrecruiting200
2027-01 est.P3Colgate Palmolive CLNCT07842991 Clinical Evaluation of a Toothpaste for Dental Plaque Reduction and Prevention of Gum ProblemsPlaque; Dental Plaque; Gingivitisrecruiting120
2027-01 est.P3Adneuris Therapeutics, Inc.NCT07845071 An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical OriginPainrecruiting160
2027-01 est.P2Aperta Biosciences, LLCNCT07904767 A Phase 2 Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With BlepharitisBlepharitisnot yet recruiting15
2027-01 est.P2Cristcot LLCNCT07909291 A Three-Arm, Randomized, Placebo-Controlled, Double-Blind Phase 2 Study to Evaluate the Safety and Efficacy of Two Dosage Regimens of a Novel Hydrocortisone AceHemorrhoidal Diseasenot yet recruiting78
2027-01-01 est.P2SIGA Technologies SIGANCT04957485 Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOSSmallpoxactive not recruiting100
2027-01-01 est.P2Biotheus Inc.NCT05879055 A Study of PM8002 in Combination With Chemotherapy in Patients With NENNeuroendocrine Neoplasmactive not recruiting31
2027-01-01 est.P2Tasly Biopharmaceuticals Co., Ltd.NCT06838546 A Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Colorectal CancerAdvanced Colorectal Cancernot yet recruiting80
2027-01-01 est.P1/P2Second Life TherapeuticsNCT07341737 SL-28 for Advanced Solid TumoursHead & Neck Cancer; Pancreas Carcinoma; Pancreas Cancer, Metastatic; Lung Adenocarcinoma; Lung Cancerecruiting60
2027-01-03 est.P2Shenzhen Kangzhe Biotechnology Co., Ltd.NCT07402369 Phase II Study of CMS-D002 Capsule for Uterine Fibroids With MenorrhagiaUterine Fibroids With Menorrhagiarecruiting120
2027-01-04 est.P3MoonLake Immunotherapeutics AG MLTXNCT06641089 Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponseArthritis, Psoriaticactive not recruiting600
2027-01-04 est.P3AstraZeneca AZNNCT07000136 A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFHHeterozygous Familial Hypercholesterolaemiaactive not recruiting473
2027-01-05 est.P1/P2Hangzhou Sciwind Biosciences Co., Ltd.NCT07243171 A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With OverweOverweight and/or Obesity; Weight Managementrecruiting126
2027-01-05 est.P3Shanghai Mabgeek Biotech.Co.LtdNCT07540442 A Phase III Study of MG-K10 in Adolescents With Moderate-to-Severe Atopic DermatitisDermatitis, Atopicnot yet recruiting180
2027-01-06 est.P3AstraZeneca AZNNCT05925803 Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)Systemic Sclerosis; Sclerodermaactive not recruiting314
2027-01-06 est.P1/P2Amgen AMGNNCT06401044 A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye DiseaseThyroid Eye Diseaseactive not recruiting94
2027-01-06 est.P1/P2Bristol-Myers Squibb BMYNCT06481306 A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell DiseaseAnemia, Sickle Cell; Healthy Volunteersrecruiting224
2027-01-06 est.P1/P2Incyte Corporation INCYNCT06843408 A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHDChronic Graft-versus-host-diseaseactive not recruiting32
2027-01-06 est.P3NorgineNCT07218523 A Study to Investigate Bowel Cleansing With PLENVU® Compared to Sodium Picosulfate in Participants Aged 1 to < 18 Years of Age in Preparation for ColonoscopyBowel Cleansing Prior to Clinical Proceduresrecruiting212
2027-01-07 est.P3Sanofi SNYNCT07247188 Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell DiseaseSickle Cell Diseaserecruiting100
2027-01-08 est.P3AstraZeneca AZNNCT05221840 A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Non-Small Cell Lung Canceractive not recruiting1051
2027-01-08 est.P3Ocular Therapeutix, Inc. OCULNCT06495918 Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular DegenerationNeovascular Age-related Macular Degenerationactive not recruiting825
2027-01-08 est.P2Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.NCT06981091 A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of XH-S004 Tablets in PatiNon-Cystic Fibrosis Bronchiectasisactive not recruiting234
2027-01-09 est.P3GeneQuantum Healthcare (Suzhou) Co., Ltd.NCT07673029 A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast CancerHER2-positive Breast Cancerrecruiting228
2027-01-10 est.P3CelgeneNCT05519085 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Relapsed or Refractory Multiple Myelomarecruiting810
2027-01-11 est.P1/P2LaNova Medicines LimitedNCT05615974 A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant TumorsMalignant Tumorsrecruiting139
2027-01-11 est.P3FutureGen Biopharmaceutical (Beijing) Co., LtdNCT06177041 M108 Plus CAPOX Versus Placebo Plus CAPOX as First-line Treatment for Claudin (CLDN) 18.2-Positive, HER2-Negative, PD-L1 CPS<5, Locally Advanced Unresectable orLocally Advanced Unresectable or Metastatic Gastric Cancer; Locally Advanced Unresectable or Metastarecruiting486
2027-01-11 est.P3AstraZeneca AZNNCT06417814 A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGMetastatic Non-small Cell Lung Canceractive not recruiting768
2027-01-11 est.P2/P3EyeBiotech Ltd.NCT06957080 A Study of 2 Doses of Remigromig (EYE103) Compared With Ranibizumab (0.5 mg) in Participants With DMEDiabetic Macular Edema (DME)active not recruiting1054
2027-01-11 est.P3AstraZeneca AZNNCT07000123 A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD EventCardiovascular Diseaseactive not recruiting3103
2027-01-12 est.P3Merck Sharp & Dohme LLC MRKNCT05609968 Study of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembrolizumab for Participants With Metastatic Non-small Cell LungCarcinoma, Non-Small-Cell Lungactive not recruiting614
2027-01-12 est.P2GlaxoSmithKlineNCT07092865 A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following RRespiratory Syncytial Virus Infectionsactive not recruiting168
2027-01-13 est.P3iVascular S.L.U.NCT05952206 Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet TherapyCoronary Artery Diseaseactive not recruiting2312
2027-01-13 est.P1/P2Avirmax Biopharma IncNCT06550011 Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54-VEGF Trap) in Subjects With NNeovascular (Wet) AMDactive not recruiting18
2027-01-13 est.P3AstraZeneca AZNNCT06706817 A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With TezepelumabChronic Rhinosinusitis With Nasal Polypsactive not recruiting181
2027-01-13 est.P3AkesoNCT06951503 AK112 and Chemotherapy in First-line Metastatic Colorectal CancerColorectal Adenocarcinomarecruiting560
2027-01-14 est.P3Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. SBFMNCT07261644 A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS)Ankylosing Spondylitisrecruiting500
2027-01-14 est.P2Novo Nordisk A/S NVONCT07395687 A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or ObesityOverweight; Obesityrecruiting333
2027-01-15 est.P3Merck Sharp & Dohme LLC MRKNCT04199689 Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)Papillomavirus Infectionsactive not recruiting6033
2027-01-15 est.P3Bioverativ, a Sanofi companyNCT04644575 Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia AHemophilia Aactive not recruiting261
2027-01-15 est.P3Regeneron Pharmaceuticals REGNNCT05608291 A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it HasMelanomaactive not recruiting1564
2027-01-15 est.P2/P3IDEAYA Biosciences IDYANCT05987332 IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal MelanomaMetastatic Uveal Melanomaactive not recruiting420
2027-01-15 est.P2XBiotech, Inc. XBITNCT06590090 Natrunix in Combination With Methotrexate for Rheumatoid Arthritis TreatmentRheumatoid Arthritisnot yet recruiting108
2027-01-15 est.P2Biostar Pharma, Inc.NCT06764940 A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain MetastasesHER2-negative Breast Cancer Patients With Brain Metastasesrecruiting120
2027-01-15 est.P2Huabo Biopharm Co., Ltd.NCT07376629 A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBCTNBCenrolling by invitation60
2027-01-16 est.P1/P2Corbus Pharmaceuticals Inc. CRBPNCT06265727 A Phase 1/2 Study to Investigate CRB-701 in Solid TumorsSolid Tumor, Adultrecruiting348
2027-01-16 est.P3Novartis Pharmaceuticals NVSNCT07102628 Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary SyndromesAcute Coronary Syndromeactive not recruiting305
2027-01-18 est.P3Pfizer PFENCT05035212 Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults.Lower Respiratory Tract Illnessactive not recruiting38861
2027-01-18 est.P3Takeda TAKNCT05319353 A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in CCytomegalovirus (CMV)recruiting80
2027-01-18 est.P2AstraZeneca AZNNCT05374603 Savolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLCLung Canceractive not recruiting47
2027-01-18 est.P1/P2Centre for Neuro SkillsNCT05786729 Aerobic Exercise After Traumatic Brain InjuryTraumatic Brain Injuryenrolling by invitation190
2027-01-18 est.P1/P2Sanofi Pasteur, a Sanofi Company SNYNCT06686654 Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 YeaHuman Metapneumovirus Immunization; Respiratory Syncytial Virus Immunizationactive not recruiting1530
2027-01-19 est.P3Hoffmann-La RocheNCT05170204 A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung CNon-Small Cell Lung Canceractive not recruiting68
2027-01-19 est.P1/P2Sanofi SNYNCT05584670 A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid TumorsSolid Tumorrecruiting542
2027-01-20 est.P1/P2Creative Medical Technology Holdings Inc CELZNCT06053242 Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back PainChronic Low-back Pain; Degenerative Disc Diseaseactive not recruiting45
2027-01-20 est.P2/P3Turn Therapeutics TTRXNCT07355075 A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic DermatiEczema Atopic Dermatitis; Eczema; Atopic Dermatitisrecruiting190
2027-01-21 est.P3TG Therapeutics, Inc. TGTXNCT05877963 Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabRelapsing Multiple Sclerosisrecruiting800
2027-01-21 est.P3Amgen AMGNNCT06858839 Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are OverweightObesityactive not recruiting3853
2027-01-21 est.P3Amgen AMGNNCT06858878 Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are OverweightType 2 Diabetes Mellitus (T2DM), Obesity, Overweightactive not recruiting1105
2027-01-21 est.P2Laboratoires TheaNCT07169695 A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal KeratoconjunctivitisModerate to Severe Vernal Keratoconjunctivitisrecruiting120
2027-01-22 est.P3Lupin Ltd.NCT07097701 An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and Safety of Mexiletine PR Compared to Mexiletine IRMyotoniarecruiting24
2027-01-23 est.P1/P2Egle TherapeuticsNCT06622486 First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid TumorsSolid Tumor, Adultrecruiting50
2027-01-24 est.P2Chengdu Syncor Pharmaceutical Co., Ltd.NCT07483671 Efficacy and Safety Study of BPR-101 Capsules in Combination With Metronidazole in BV PatientsBacterial Vaginosisnot yet recruiting80
2027-01-25 est.P1/P2Novartis Pharmaceuticals NVSNCT04699188 Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationKRAS G12C Mutant Solid Tumors; Carcinoma, Non-Small-Cell Lung; Carcinoma, Colorectal; Cancer of Lungactive not recruiting344
2027-01-25 est.P3Vertex Pharmaceuticals Incorporated VERXNCT06696443 Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)Diabetic Peripheral Neuropathic Painactive not recruiting455
2027-01-25 est.P3Novo Nordisk A/S NVONCT07076199 A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With InsDiabetes Mellitus, Type 1active not recruiting877
2027-01-25 est.P3Pfizer PFENCT07653100 A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreFRespiratory Syncytial Virus (RSV)recruiting540
2027-01-26 est.P3GlaxoSmithKlineNCT05757102 A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With AsthmaAsthmaactive not recruiting138
2027-01-28 est.P3Novartis Pharmaceuticals NVSNCT05038735 Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After TreatmBreast Canceractive not recruiting210
2027-01-28 est.P3ModernaTX, Inc.NCT07496450 A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy AdultsInfluenzaactive not recruiting4050
2027-01-29 est.P1/P2IDEAYA Biosciences IDYANCT03947385 Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsMetastatic Uveal Melanoma; Cutaneous Melanoma; Colorectal Cancer; Other Solid Tumorsrecruiting336
2027-01-29 est.P2Novartis Pharmaceuticals NVSNCT04544189 Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women WitBreast Neoplasmsactive not recruiting69
2027-01-29 est.P3Novartis Pharmaceuticals NVSNCT04817618 Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.C3Grecruiting98
2027-01-29 est.P3Seagen, a wholly owned subsidiary of PfizerNCT05911295 Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2Urothelial Carcinomaactive not recruiting412
2027-01-29 est.P3Novo Nordisk A/S NVONCT06118281 ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart AttackCardiovascular Risk; Acute Myocardial Infarction (AMI)active not recruiting10000
2027-01-29 est.P1/P2AstraZeneca AZNNCT06151964 A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and OverweightOverweight and Obesityactive not recruiting166
2027-01-29 est.P2Dynavax Technologies CorporationNCT07207408 Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of AgePrevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersinia Pestisactive not recruiting148
2027-01-30 est.P3Tolmar Inc.NCT04906395 Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast CancerBreast Canceractive not recruiting250
2027-01-30 est.P1/P2Shanghai Runshi Pharmaceutical Technology Co., LtdNCT06132217 A Study of Simmitinib Plus SG001 in Advanced Solid TumorsAdvanced Solid Tumornot yet recruiting168
2027-01-30 est.P2CurasightNCT06474806 Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate CancerProstate Cancerrecruiting168
2027-01-30 est.P1/P2Psivac LtdNCT06549946 Ixovex-1 Single Agent and Combination TherapySolid Tumor; Head and Neck Cancerrecruiting18
2027-01-30 est.P3Hoffmann-La RocheNCT06589986 A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to SeverModerately to Severely Active Ulcerative Colitisactive not recruiting400
2027-01-30 est.P3Shanghai Runshi Pharmaceutical Technology Co., LtdNCT06656091 A Study of Simmitinib Versus Chemotherapy for Participants With Advanced Oesophageal Squamous Cell CarcinomaAdvanced Oesophageal Squamous Cell Carcinomanot yet recruiting450
2027-01-30 est.P3Sinovac Biotech Co., Ltd SVANCT07055893 Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis RegimenRabies (Healthy Volunteers)not yet recruiting390
2027-01-31 est.P2Scancell Ltd SCNLDNCT04079166 SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)Malignant Melanoma; Melanoma (Skin); Melanoma Stage III; Melanoma Stage IVactive not recruiting173
2027-01-31 est.P3Merck Sharp & Dohme LLC MRKNCT04241185 Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-99Urinary Bladder Neoplasmsactive not recruiting520
2027-01-31 est.P2Daiichi Sankyo Co., Ltd.NCT04433234 Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular DystrophyDuchenne Muscular Dystrophyactive not recruiting8
2027-01-31 est.P3ActelionNCT05179876 A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other OptionHypertension, Pulmonaryrecruiting280
2027-01-31 est.P1/P2Creative Medical Technology Holdings Inc CELZNCT05626712 Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 DiabetesType 1 Diabetes; Diabetes Mellitus, Type 1recruiting18
2027-01-31 est.P3iRenix Medical, Inc.NCT05750589 Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal InjectionsRetinal Diseasenot yet recruiting240
2027-01-31 est.P1/P2Janssen Research & Development, LLCNCT05908734 A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung CancerCarcinoma, Non-Small-Cell Lungactive not recruiting71
2027-01-31 est.P2Grit BiotechnologyNCT06241781 Autologous Tumor Infiltrating Lymphocytes Injection (GT101 Injection) for the Treatment of Recurrent or Metastatic Cervical CancerRecurrent or Metastatic Cervical Cancerrecruiting100
2027-01-31 est.P1/P2EXO Biologics S.A.NCT06279741 Safety and Efficacy of MSC-EVs in the Prevention of BPD in Extremely Preterm InfantsBronchopulmonary Dysplasiarecruiting265
2027-01-31 est.P3Ono Pharmaceutical Co., Ltd.NCT06579573 ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.Epilepsy, Generalizedrecruiting15
2027-01-31 est.P2Ono Pharmaceutical Co., Ltd.NCT06590896 Safety of Cenobamate in Japanese Subjects With Partial Onset SeizuresEpilepsies, Partialrecruiting100
2027-01-31 est.P2Shanghai Runshi Pharmaceutical Technology Co., LtdNCT06739213 A Phase II Study of SYHA1813 for Recurrent or Progressive High-Grade MeningiomaRecurrent or Progressive High Grade Meningiomanot yet recruiting56
2027-01-31 est.P2NeuroBiogen Co., LtdNCT07009171 Study to Evaluate the Efficacy and Safety of KDS2010 in Overweight or Obese PatientsOverweight; Obesity; Obese Patientsrecruiting75
2027-01-31 est.P2MediLink Therapeutics (Suzhou) Co., Ltd.NCT07202364 A Study of YL202 in Patients With Advanced Solid TumorsNon Small Cell Lung Cancer; Colorectal Cancer; Cervical Cancer; Locally Advanced or Metastatic Solidrecruiting100
2027-01-31 est.P2Miltenyi Biomedicine GmbHNCT07288879 DALY II Japan/MB-CART2019.1 for DLBCLDLBCL - Diffuse Large B Cell Lymphoma; CAR T Cell Therapyrecruiting31
2027-01-31 est.P2Dermavon Holdings LimitedNCT07465120 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ⅱ Clinical Study to Evaluate the Efficacy and Safety of CMS-D001 in Adult Patients With ModerModerate to Severe Atopic Dermatitisnot yet recruiting160
2027-01-31 est.P2/P3Quoin Pharmaceuticals QNRXNCT07538583 Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton SyndromeNetherton Syndromerecruiting16
2027-01-31 est.P2CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.NCT07940075 SYH2062 Injection in Participants With Mild to Moderate Essential Hypertension .Mild to Moderate Primary Hypertensionrecruiting360

← 2026-12 | 2027-02 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.